Revenue
2017
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $80.3M | $69.3M | $58.5M | $41.4M | $29.5M | $18.2M | $15.4M | $8.3M | $4.2M |
| Gross profit | $54.3M | $46.5M | $40.1M | $27.0M | $18.8M | $11.2M | $9.3M | $2.9M | $2.5M |
| Gross margin | 67.69% | 67.08% | 68.62% | 65.30% | 63.85% | 61.68% | 60.03% | 35.56% | 59.65% |
| Research & development | $9.2M | $8.8M | $9.6M | $8.9M | $6.7M | $4.3M | $4.2M | $4.3M | $5.8M |
| Operating expenses | $88.1M | $88.2M | $84.2M | $66.1M | $48.3M | $36.5M | $28.4M | $20.7M | $19.5M |
| Operating income | −$33.8M | −$34.1M | −$44.1M | −$39.0M | −$29.5M | −$25.3M | −$19.2M | −$17.8M | −$16.9M |
| Operating margin | −42.05% | −49.23% | −75.40% | −94.18% | −99.96% | −138.77% | −124.06% | −214.91% | −398.68% |
| EBITDA | −$33.1M | −$33.5M | −$43.6M | −$38.6M | −$29.2M | −$25.1M | −$18.9M | −$17.3M | −$16.2M |
| EBITDA margin | −41.26% | −48.32% | −74.67% | −93.25% | −99.18% | −137.56% | −122.26% | −209.32% | −380.75% |
| Net income | −$38.8M | −$37.8M | −$46.7M | −$44.3M | −$33.3M | −$28.8M | −$22.4M | −$21.1M | −$21.3M |
| Net profit margin | −48.37% | −54.60% | −79.83% | −106.95% | −112.94% | −158.10% | −145.18% | −254.92% | −502.57% |
| Basic EPSper basic share | -$0.83 | -$1.33 | -$2.04 | -$2.72 | -$2.30 | -$2.23 | -$17.10 | -$101.41 | — |
| Diluted EPSper diluted share | -$0.83 | -$1.33 | -$2.04 | -$2.72 | -$2.30 | -$2.23 | -$17.10 | -$101.41 | — |
Reported shareholders
| Holder | % owned |
|---|---|
Nantahala Capital Management, LLC | 26.29%11.79M shares |
Essex Woodlands Management, Inc. | 17.21%7.71M shares |
EW Healthcare Partners Fund 2-UGP, LLC / EW HEALTHCARE PARTNERS FUND 2, L.P. / EW HEALTHCARE PARTNERS FUND 2-A, L.P. / EW Healthcare Partners Fund 2 GP, L.P. | ≈17.21%7.71M shares |
Stonepine Capital Management, LLC | 5.94%2.66M shares |
ORBIMED ADVISORS LLC / OrbiMed Capital GP IV LLC | ≈5.37%2.41M shares |
SILVERARC CAPITAL MANAGEMENT, LLC | 4.77%2.14M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 3.50%1.57M shares |
DAFNA Capital Management LLC | 3.21%1.44M shares |
PERKINS CAPITAL MANAGEMENT INC | 3.07%1.38M shares |
Sio Capital Management, LLC | 1.42%636.3K shares |
WealthTrust Axiom LLC | 1.02%457.73K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.87%389.22K shares |
BlackRock, Inc. | 0.84%374.52K shares |
Cuca Roberto | ≈0.57%257.38K shares |
VANGUARD FIDUCIARY TRUST CO | 0.48%213.14K shares |
Blizard Jeffrey | ≈0.46%205.13K shares |
Talmo Paul | ≈0.39%173.44K shares |
Firestone Gregory A. | ≈0.31%139.31K shares |
UP STRATEGIC WEALTH INVESTMENT ADVISORS LLC | 0.22%99.89K shares |
Embree Financial Group | 0.20%90.91K shares |
Percentages use 44.83M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Nov 17, 2025Form 4 | EW Healthcare Partners Fund 2-UGP, LLC +3TenPercentOwner,Other | BuyCommon Stock, par value $0.001 per share | 3.60M | $1.11 | $4.00M | 7.71M |
| Oct 24, 2024Form 4 | Cuca RobertoCOO and CFO | BuyCommon Stock | 64.4K | $2.25 | $145.0K | 155.4K |
| Oct 24, 2024Form 4 | Talmo PaulChief Technology Officer | BuyCommon Stock | 22.2K | $2.25 | $50.0K | 91.1K |
| Oct 24, 2024Form 4 | KOBLISH ANTONYChief Executive Officer | BuyCommon Stock | 88.9K | $2.25 | $200.0K | 458.9K |
| Oct 24, 2024Form 4 | Firestone Gregory A.Chief Commercial Officer | BuyCommon Stock | 6.7K | $2.25 | $15.0K | 57.3K |